Your browser doesn't support javascript.
loading
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.
Li, Feng-Fei; Jiang, Lanlan; Fu, Liyuan; Zhu, Hong-Hong; Zhou, Peihua; Zhang, Danfeng; Su, Xiao-Fei; Wu, Jin-Dan; Ye, Lei; Ma, Jian-Hua.
Afiliação
  • Li FF; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Jiang L; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Fu L; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhu HH; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhou P; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhang D; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Su XF; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wu JD; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Ye L; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
  • Ma JH; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. majianhua196503@126.com.
Diabetes Ther ; 8(1): 177-187, 2017 Feb.
Article em En | MEDLINE | ID: mdl-27995593
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article